CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8622)
All Articles published online
|
Publishing Process of This Article
|
Jun 10, 2019 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Psychiatry
ISSN
2220-3206
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tampi RR, Tampi DJ, Young JJ, Balachandran S, Hoq RA, Manikkara G. Evidence for using pimavanserin for the treatment of Parkinson's disease psychosis. World J Psychiatr 2019; 9(3): 47-54 [PMID: 31211112 DOI: 10.5498/wjp.v9.i3.47] |
|---|---|
| URL: | https://www.wjgnet.com/2220-3206/full/v9/i3/47.htm |
| Number | Citing Articles |
| 1 |
Karun Badwal, Shangwe A. Kiliaki, Sagar B. Dugani, Sandeep R. Pagali. Psychosis Management in Lewy Body Dementia: A Comprehensive Clinical Approach. Journal of Geriatric Psychiatry and Neurology 2022; 35(3): 255 doi: 10.1177/0891988720988916
|
| 2 |
Mark David Tricklebank, Trevor W. Robbins, Camilla Simmons, Erik H. F. Wong. Time to re-engage psychiatric drug discovery by strengthening confidence in preclinical psychopharmacology. Psychopharmacology 2021; 238(6): 1417 doi: 10.1007/s00213-021-05787-x
|
| 3 |
Jelena Stamenović, Biljana Živadinović, Vanja Đurić. Clinical characteristics and treatment of psychosis in Parkinson’s disease: A narrative review. Journal of the Chinese Medical Association 2024; 87(11): 972 doi: 10.1097/JCMA.0000000000001146
|
| 4 |
Milagros Rojas, Mervin Chávez-Castillo, Pablo Duran, Ángel Ortega, María Judith Bautista-Sandoval, Juan Salazar, Manuel Riaño-Garzón, Maricarmen Chacín, Oscar Medina-Ortiz, Jim Palmar, Lorena Cudris-Torres, Valmore Bermúdez. Psychosis in Parkinson’s Disease: Looking Beyond Dopaminergic Treatments. Current Pharmaceutical Design 2022; 28(33): 2725 doi: 10.2174/1381612828666220428102802
|
| 5 |
Valentina Bashkatova. Metabotropic glutamate receptors and nitric oxide in dopaminergic neurotoxicity. World Journal of Psychiatry 2021; 11(10): 830-840 doi: 10.5498/wjp.v11.i10.830
|
| 6 |
Sweta Bhoopatiraju, George Grossberg. Emerging Perspectives in the Diagnosis and Management of Depression and Psychosis in Parkinson's Disease. Neurology 2021; 17(2): 97 doi: 10.17925/USN.2021.17.2.97
|
| 7 |
Shuo Zhang, Yan Ma. Emerging role of psychosis in Parkinson's disease: From clinical relevance to molecular mechanisms. World Journal of Psychiatry 2022; 12(9): 1127-1140 doi: 10.5498/wjp.v12.i9.1127
|
| 8 |
Jie Liu, Dongdong Peng, Jinlong Li, Zong Dai, Xiaoyong Zou, Zhanchao Li. Identification of Potential Parkinson’s Disease Drugs Based on Multi-Source Data Fusion and Convolutional Neural Network. Molecules 2022; 27(15): 4780 doi: 10.3390/molecules27154780
|
| 9 |
Adrian Espiritu, Carl Frolian Leochico, Calvin H. Hirsch, Nicole E. Marlatt, Amer M. Burhan. Geriatric Psychiatry. 2024; : 561 doi: 10.1007/978-3-031-47802-4_22
|
| 10 |
Xiaoyin Zhu, Yue Yang, Guangying Du, Bin Liu, Xin Yu, Liang Ye, Yutong Mao, Hongbo Wang, Jingwei Tian. Non-clinical pharmacology and toxicology studies of LPM6690061, a novel 5-hydroxytryptamine (5-HT)2A receptor inverse agonist. Food and Chemical Toxicology 2023; 176: 113800 doi: 10.1016/j.fct.2023.113800
|
| 11 |
Yung-Chih Kuo, He-Cheng Tsai, Rajendiran Rajesh. Glutathione Liposomes Carrying Ceftriaxone, FK506, and Nilotinib to Control Overexpressed Dopamine Markers and Apoptotic Factors in Neurons. ACS Biomaterials Science & Engineering 2021; 7(7): 3242 doi: 10.1021/acsbiomaterials.1c00555
|
| 12 |
Sagar Suman Panda, Ravi kumar Venkata Varaha Bera, Jnyanaranjan Panda. Chemometry-assisted Diffuse Reflectance Infrared Fourier Transform Spectroscopy (DRIFTS) method for quantification of a novel antipsychotic agent in pharmaceuticals: A case study on ICH Q 14 concept. Vibrational Spectroscopy 2020; 107: 103039 doi: 10.1016/j.vibspec.2020.103039
|
| 13 |
Saloni Seth, Saurabh Saurabh, Dinesh Kataria, Shiv Prasad, Prerna Kukreti. NEUROPSYCHIATRIC ASPECTS OF MOVEMENT DISORDERS. INDIAN JOURNAL OF APPLIED RESEARCH 2022; : 28 doi: 10.36106/ijar/1901380
|